14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today BLUE ranks #12281 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

bluebird bio Stock Forecast NASDAQ:BLUE

$8.73 (2.46%)

Volume: 2M

Closed: Jan 14, 2022

Hollow Logo Score: -2.791

bluebird bio Stock Forecast

$8.73 (2.46%)

Volume: 2M

Closed: Jan 14, 2022

Score Hollow Logo -2.791

bluebird bio Stock Price (Quote) NASDAQ:BLUE

$8.73 ( 2.46% ) Friday, 14th Jan 2022

Range Low Price High Price Comment
30 days $8.12 $11.70 Friday, 14th Jan 2022 BLUE stock ended at $8.73. This is 2.46% more than the trading day before Thursday, 13th Jan 2022. During the day the stock fluctuated 7.09% from a day low at $8.18 to a day high of $8.76.
90 days $8.12 $25.39
52 weeks $8.12 $52.80

Historical bluebird bio prices

Date Open High Low Close Volume
2022-01-14 $8.57 $8.76 $8.18 $8.73 2 062 269
2022-01-13 $8.87 $9.08 $8.50 $8.52 1 753 878
2022-01-12 $9.54 $9.57 $8.90 $8.92 1 318 219
2022-01-11 $9.47 $9.85 $9.46 $9.57 1 215 038
2022-01-10 $9.36 $9.43 $8.96 $9.41 1 835 121
2022-01-07 $9.77 $10.07 $9.53 $9.55 918 970
2022-01-06 $9.94 $10.15 $9.69 $9.80 1 390 300
2022-01-05 $10.24 $10.51 $9.90 $9.91 1 285 421
2022-01-04 $10.58 $10.74 $10.12 $10.28 986 808
2022-01-03 $10.09 $10.68 $10.09 $10.60 1 234 823
2021-12-31 $10.43 $10.64 $9.91 $9.99 1 345 815
2021-12-30 $10.42 $10.84 $10.31 $10.35 1 533 650
2021-12-29 $10.74 $10.82 $10.26 $10.41 857 922
2021-12-28 $10.93 $11.58 $10.77 $10.77 2 489 631
2021-12-27 $11.38 $11.43 $10.77 $10.94 4 161 581
2021-12-23 $11.21 $11.70 $11.07 $11.40 1 852 042
2021-12-22 $11.49 $11.55 $11.04 $11.12 2 709 667
2021-12-21 $10.50 $11.59 $10.37 $11.58 2 890 124
2021-12-20 $8.45 $10.76 $8.12 $10.71 9 153 305
2021-12-17 $9.14 $10.69 $9.11 $10.62 8 873 007
2021-12-16 $9.56 $9.87 $9.30 $9.37 1 338 206
2021-12-15 $9.22 $9.51 $8.83 $9.51 2 239 000
2021-12-14 $9.40 $9.74 $9.14 $9.16 2 221 988
2021-12-13 $9.48 $9.69 $8.98 $9.51 4 405 942
2021-12-10 $9.33 $9.47 $8.90 $8.96 1 280 183
2021-12-09 $9.89 $9.96 $9.37 $9.38 1 665 072
2021-12-08 $10.04 $10.06 $9.70 $10.00 1 600 482
2021-12-07 $10.07 $10.35 $9.85 $9.95 1 617 130
2021-12-06 $9.90 $10.19 $9.79 $10.01 1 360 100
2021-12-03 $10.63 $10.65 $9.88 $9.95 1 216 333
2021-12-02 $9.97 $10.68 $9.84 $10.63 1 501 360
2021-12-01 $10.22 $10.77 $10.05 $10.05 1 464 514
2021-11-30 $10.16 $10.46 $9.89 $10.11 1 531 287
2021-11-29 $10.76 $10.90 $10.30 $10.33 1 305 921
2021-11-26 $10.60 $10.89 $10.35 $10.50 1 816 606
2021-11-24 $10.59 $10.92 $10.46 $10.76 4 602 460
2021-11-23 $10.39 $10.75 $10.21 $10.73 1 691 563
2021-11-22 $11.31 $11.36 $10.40 $10.54 2 179 677
2021-11-19 $10.80 $11.05 $10.54 $10.70 1 418 962
2021-11-18 $11.34 $11.34 $10.76 $10.91 1 637 524
2021-11-17 $11.55 $11.60 $11.09 $11.31 1 163 901
2021-11-16 $11.48 $11.65 $11.23 $11.58 1 705 576
2021-11-15 $11.80 $11.81 $11.12 $11.48 1 314 685
2021-11-12 $11.50 $11.76 $11.13 $11.68 1 667 090
2021-11-11 $11.28 $12.12 $11.25 $11.68 2 209 858
2021-11-10 $10.73 $11.74 $10.60 $11.31 4 420 338
2021-11-09 $10.70 $10.88 $10.35 $10.88 3 746 705
2021-11-08 $12.62 $12.62 $10.59 $10.70 8 177 711
2021-11-05 $17.74 $17.85 $12.90 $13.14 6 123 474
2021-11-04 $24.95 $25.39 $23.98 $25.19 830 522

About bluebird bio

bluebird bio bluebird bio, Inc., a clinical-stage biotechnology company, focuses on developing transformative gene therapies for severe genetic and rare diseases. Its product candidates include Lenti-D, which is in phase II/III clinical studies for the treatment of cerebral adrenoleukodystrophy, a rare, hereditary neurological disorder; and LentiGlobin that is in phase I/II clinical studies for the treatment of beta-thalassemia major and severe sickle cell di... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT